Literature DB >> 7927944

Expression of the FGFR1 gene in human breast-carcinoma cells.

J Jacquemier1, J Adelaide, P Parc, F Penault-Llorca, J Planche, O deLapeyriere, D Birnbaum.   

Abstract

Fibroblast growth factors (FGF) constitute a family of at least 9 members which act through high-affinity tyrosine-kinase receptors encoded by 4 distinct genes. In humans, the FGFR1 gene is located in chromosomal region 8p12. Its amplification and expression were examined in a panel of 110 breast carcinoma samples by Southern- and Northern-blot analyses. FGFR1 was amplified in 9% and overexpressed in about 15% of the tumors studied. In situ hybridization experiments were performed on tissue sections of normal breast and tumors with a high level of FGFR1 expression. In both normal and tumoral tissues, FGFR1 RNA was detected in the epithelial cells. Overexpression of FGFR1 seems to be associated with small, well-differentiated diploid tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927944     DOI: 10.1002/ijc.2910590314

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.

Authors:  S La Rosa; F Sessa; L Colombo; M G Tibiletti; D Furlan; C Capella
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Transitions from mono- to co- to tri-culture uniquely affect gene expression in breast cancer, stromal, and immune compartments.

Authors:  Mary C Regier; Lindsey J Maccoux; Emma M Weinberger; Keil J Regehr; Scott M Berry; David J Beebe; Elaine T Alarid
Journal:  Biomed Microdevices       Date:  2016-08       Impact factor: 2.838

3.  Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer.

Authors:  Luigi Formisano; Kimberly M Stauffer; Christian D Young; Neil E Bhola; Angel L Guerrero-Zotano; Valerie M Jansen; Mónica M Estrada; Katherine E Hutchinson; Jennifer M Giltnane; Luis J Schwarz; Yao Lu; Justin M Balko; Olivier Deas; Stefano Cairo; Jean-Gabriel Judde; Ingrid A Mayer; Melinda Sanders; Teresa C Dugger; Roberto Bianco; Thomas Stricker; Carlos L Arteaga
Journal:  Clin Cancer Res       Date:  2017-07-27       Impact factor: 12.531

4.  Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study.

Authors:  Lucia Nogova; Lecia V Sequist; Jose Manuel Perez Garcia; Fabrice Andre; Jean-Pierre Delord; Manuel Hidalgo; Jan H M Schellens; Philippe A Cassier; D Ross Camidge; Martin Schuler; Ulka Vaishampayan; Howard Burris; G Gary Tian; Mario Campone; Zev A Wainberg; Wan-Teck Lim; Patricia LoRusso; Geoffrey I Shapiro; Katie Parker; Xueying Chen; Somesh Choudhury; Francois Ringeisen; Diana Graus-Porta; Dale Porter; Randi Isaacs; Reinhard Buettner; Jürgen Wolf
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

5.  RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.

Authors:  Katia Cailliau; Arlette Lescuyer; Anne-Françoise Burnol; Álvaro Cuesta-Marbán; Christian Widmann; Edith Browaeys-Poly
Journal:  J Biol Chem       Date:  2015-06-24       Impact factor: 5.157

6.  Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.

Authors:  U Wagner; L Bubendorf; T C Gasser; H Moch; J P Görög; J Richter; M J Mihatsch; F M Waldman; G Sauter
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

7.  Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.

Authors:  Alok R Khandelwal; Burton Kent; Savage Hillary; Md Maksudul Alam; Xiaohua Ma; Xin Gu; John DiGiovanni; Cherie-Ann O Nathan
Journal:  Mol Carcinog       Date:  2019-06-29       Impact factor: 4.784

8.  Discovery of novel fibroblast growth factor receptor 1 kinase inhibitors by structure-based virtual screening.

Authors:  Krishna P Ravindranathan; Valsan Mandiyan; Anil R Ekkati; Jae H Bae; Joseph Schlessinger; William L Jorgensen
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

9.  FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.

Authors:  Joshua Z Drago; Luigi Formisano; Carlos L Arteaga; Aditya Bardia; Dejan Juric; Andrzej Niemierko; Alberto Servetto; Seth A Wander; Laura M Spring; Neelima Vidula; Jerry Younger; Jeffrey Peppercorn; Megan Yuen; Giuliana Malvarosa; Dennis Sgroi; Steven J Isakoff; Beverly Moy; Leif W Ellisen; A John Iafrate
Journal:  Clin Cancer Res       Date:  2019-08-01       Impact factor: 12.531

Review 10.  Fibroblast growth factor signalling: from development to cancer.

Authors:  Nicholas Turner; Richard Grose
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.